Arteris, Inc. (NASDAQ:AIP) Given Consensus Rating of "Moderate Buy" by Brokerages

Key Points

• Arteris has a “Moderate Buy” consensus rating from six analysts, with five Buys and one Sell. The average 12-month price target is $41, while Jefferies’ upgrade to Buy included a $50 target.
• Second-quarter revenue of $24.13 million exceeded expectations, but the company reported an adjusted loss of $0.10 per share versus an expected loss of roughly $0.04–$0.05. Arteris nevertheless issued above-consensus third-quarter and full-year 2026 revenue guidance.
• Insiders sold approximately 1.5 million shares worth $52.2 million over the past quarter, though insiders still own 23.3% of the company. Institutional ownership stands at 64.36%, including a new $160.1 million BlackRock position.

Arteris, Inc. (NASDAQ:AIP - Get Free Report) has been given a consensus rating of "Moderate Buy" by the six research firms that are covering the company, Marketbeat reports. One analyst has rated the stock with a sell recommendation and five have assigned a buy recommendation to the company. The average 12-month price target among brokerages that have issued ratings on the stock in the last year is $41.00.

Several brokerages have recently weighed in on AIP. Rosenblatt Securities reiterated a "buy" rating and set a $38.00 price objective on shares of Arteris in a report on Friday. Oppenheimer started coverage on shares of Arteris in a report on Thursday, July 16th. They issued an "outperform" rating and a $40.00 target price for the company. Roth Capital initiated coverage on shares of Arteris in a research note on Tuesday, August 4th. They set a "buy" rating and a $40.00 price target on the stock. Northland Securities set a $38.00 price target on shares of Arteris in a report on Wednesday, May 13th. Finally, Jefferies Financial Group raised shares of Arteris from a "hold" rating to a "buy" rating and set a $50.00 price objective for the company in a research note on Friday.

Insider Transactions at Arteris

In related news, CEO K Charles Janac sold 192,686 shares of Arteris stock in a transaction on Thursday, July 2nd. The stock was sold at an average price of $36.32, for a total value of $6,998,355.52. Following the transaction, the chief executive officer owned 8,555,047 shares in the company, valued at approximately $310,719,307.04. This trade represents a 2.20% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Saiyed Atiq Raza sold 70,000 shares of the business's stock in a transaction dated Monday, June 1st. The shares were sold at an average price of $36.02, for a total value of $2,521,400.00. Following the sale, the director directly owned 140,000 shares of the company's stock, valued at approximately $5,042,800. This trade represents a 33.33% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders sold 1,498,949 shares of company stock valued at $52,200,293. Corporate insiders own 23.30% of the company's stock.

Institutional Trading of Arteris

A number of institutional investors have recently modified their holdings of AIP. BlackRock Inc. acquired a new stake in Arteris during the 2nd quarter worth approximately $160,129,000. Deutsche Bank AG acquired a new position in Arteris during the second quarter valued at approximately $1,767,000. Mitsubishi UFJ Asset Management Co. Ltd. purchased a new stake in Arteris during the second quarter worth approximately $53,000. Bank of New York Mellon Corp purchased a new stake in Arteris during the second quarter worth approximately $4,779,000. Finally, State of Wyoming purchased a new stake in Arteris during the second quarter worth approximately $165,000. Hedge funds and other institutional investors own 64.36% of the company's stock.

Arteris News Roundup

Here are the key news stories impacting Arteris this week:

• Positive Sentiment: Jefferies upgraded Arteris from Hold to Buy and assigned a $50 price target, indicating substantial potential upside. Jefferies upgrade
• Positive Sentiment: Rosenblatt Securities reaffirmed its Buy rating and raised or maintained a $38 price target, while Roth Capital also initiated coverage with a Buy rating and a $40 target. The endorsements strengthen the bullish analyst backdrop for AIP. Rosenblatt rating Roth Capital rating
• Positive Sentiment: Arteris projected third-quarter revenue of $24 million to $25 million and updated full-year 2026 revenue guidance to $95 million to $98 million. Both ranges exceed consensus estimates of approximately $23.5 million and $94.2 million, respectively. Arteris results and guidance
• Neutral Sentiment: The company appointed Saurabh Sinha as chief financial officer and chief accounting officer, effective September 8, 2026. The leadership change may improve financial oversight, but investors may initially monitor the transition. CFO appointment
• Negative Sentiment: Second-quarter adjusted results showed a loss of $0.10 per share, worse than the expected loss of roughly $0.04-$0.05. Revenue of $24.13 million exceeded estimates, but the larger-than-expected loss likely drove selling pressure. Arteris second-quarter results
• Negative Sentiment: Recent filings disclosed sales by CEO K. Charles Janac, director Saiyed Atiq Raza, major shareholder Bayview Legacy and Vice President Paul Alpern. The concentration of insider selling may weigh on sentiment, although insiders retain significant positions.

Arteris Stock Performance

Arteris stock opened at $29.78 on Monday. The firm has a market capitalization of $1.46 billion, a P/E ratio of -34.23 and a beta of 1.96. The stock has a fifty day moving average price of $35.94 and a 200 day moving average price of $26.25. Arteris has a 52 week low of $8.42 and a 52 week high of $50.26. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.17.

Arteris (NASDAQ:AIP - Get Free Report) last issued its quarterly earnings results on Thursday, August 6th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.04) by ($0.06). The business had revenue of $24.13 million during the quarter, compared to analysts' expectations of $23.48 million. Equities research analysts anticipate that Arteris will post -0.58 earnings per share for the current year.

About Arteris

Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company's core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.

Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source